NEWPORT BEACH, Calif. and SALT LAKE CITY, Oct. 13, 2020 (GLOBE NEWSWIRE) — VERB Technology Company, Inc. (NASDAQ: VERB) (“VERB” or the “Company”), a leader in interactive video-based sales enablement applications, including interactive livestream ecommerce, webinar, CRM and marketing applications for entrepreneurs and enterprises, today announced the appointments of Mitch Bledsoe as Chief Information Officer and Julie Holdren as Chief Product Officer. The new executives will be instrumental in driving the Company’s product solutions and scaling its global information technology (IT) infrastructure.
Mr. Bledsoe joins VERB with decades of leadership under his belt, including nearly 20 years of strategic IT senior leadership experience across the high tech, financial services, advertising and retail industries. He has served as vice president at ALLDATA, Assurant, iHeartMedia and First American Corporation, leading multiple domestic and international teams through successful large-scale product development efforts, legacy modernizations, corporate applications, and the buildout and maintenance of IT
DALLAS, Oct. 13, 2020 /PRNewswire/ — LinkAmerica announces Pablo Salazar, former Chief Information Officer and Chief Compliance Officer at AT&T Mexico, as their new Chief Technology Officer to strengthen and expand LinkAmerica’s IT initiatives.
Mr. Salazar brings with him a trailblazing background in the IT and IT Security functions as well as in digital transformation roles with over 28 years of experience in the USA and Global markets. With extensive proficiency and in-depth knowledge of the diverse areas of Technology, he has managed a team of over 1,300 IT professionals and was previously responsible for integrating multiple organizations and leading the IT teams in more than 45 countries in the LATAM, EMEA, and AP Regions.
Mr. Salazar holds BSEE and MBA degrees from the University of Miami and participated in Executive Programs at Columbia University (Digital Business Leadership) and Harvard University (Achieving Breakthrough Service). Outside of AT&T, he
COLUMBIA, S.C.–(Business Wire)–Seibels is pleased to announce the appointment of Rao Tadepalli to Chief Information Officer. Mr. Tadepalli will oversee Seibels’ Information Technology Services which includes software development, implementation and support, data center operations and infrastructure. Tadepalli will also lead the digital transformation efforts and insurtech initiatives.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201013005650/en/
Rao Tadepalli, Chief Information Officer, Seibels (Photo: Business Wire)
With over 25 years of insurance and technology management expertise, Mr. Tadepalli most recently served as Chief Information Officer at Great American Insurance, a specialty property and casualty insurer. In that role, Mr. Tadepalli led process improvements and technology transformation that earned Celent’s Model Insurer Award in 2017.
“Rao brings an impressive track record of results in leading digital transformation initiatives,” said Rex Huggins, Chairman & CEO of Seibels. “He will help drive the rollout of Seibels Partner Operating Technology (SPOT) Ecosystem, offering
GAITHERSBURG, Md., Oct. 13, 2020 /PRNewswire/ — MaxCyte, Inc., a global cell-based therapies and life sciences company, announces today a senior leadership promotion and appointments for two key vice president roles.
Brad Calvin has been promoted to Chief Commercial Officer. In his previous role as MaxCyte Executive Vice President, Global Commercial Operations, Mr. Calvin was responsible for leading the Company’s sales, marketing and business development functions to define product strategy, deliver new products and drive growth of its drug discovery and cell therapy businesses. In addition, Sarah Haecker Meeks, PhD, has joined the Company as Vice President, Business Development, and Steve Nardi has joined as Vice President, Manufacturing and Engineering Operations.
MaxCyte’s President & CEO Doug Doerfler, said: “Brad’s promotion is well-earned and important for MaxCyte’s future growth. Since joining MaxCyte in 2017, he has forged pivotal relationships with leading cell therapy and gene editing companies, leading
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Click to copy
RESTON, Va., Oct. 9, 2020 /PRNewswire/ — careMESH today announced that Gustavo Bonany has been appointed as chief technology officer (CTO). In this role, he will lead the development and delivery of the company’s healthcare services, oversee its software engineering team and implement technology strategies aligned with careMESH customer requirements.
Bonany has 20 years of healthcare technology experience, most recently with Voxiva, where he was senior vice president of research and development. Before Voxiva, he was the CTO at Brain Capital, building the technology infrastructure to provide internet services to enterprises partnering with micro-finance and telecommunication companies. He has seven years of experience in the financial sector, including with Wiese and NBK Banks, managing and building electronic channel services over the Internet, WAP, POS and phones.
State governments have unique challenges when it comes to budgets, workforce readiness, and technology adoption. Increasingly state and local governments have also been innovative, pushing forward AI technology to help with many operational and constituent facing operations. Carlos Rivero, Chief Data Officer for the Commonwealth of Virginia, was recently a guest on the AI Today podcast as well as a panelist during the recent Data for AI Week Virtual Conference to discuss how states, and in particular the Commonwealth of Virginia, is leveraging data, automation, and cognitive technologies.
In an interview for this article, Carlos shares how automation, advanced data analytics, and AI play an increasing role in state government, some unique challenges around data at the state level, some interesting or surprising insights you can share about how Virginia is using ML and AI and more.
With help from Eric Geller, John Hendel, Nancy Scola and Carmen Paun
Editor’s Note: Morning Tech is a free version of POLITICO Pro Technology’s morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories.Act on the news with POLITICO Pro.
PROGRAMMING NOTE: Morning Tech will not publish Monday, Oct. 12. We’ll return to our normal schedule on Tuesday, Oct. 13. In the meantime, please continue to follow Pro Technology.
— DNC CTO talks disinformation:The DNC’s chief technology officer said the party is seeing as much disinformation from domestic sources as from foreign ones, which she called “deeply troubling.”
— Meanwhile, on the RNC: The Trump campaign and Republican National Committee are sourcing Americans’ answers on whether social media companies “are trying to help Joe
CAMBRIDGE, Md., Oct. 9, 2020 /PRNewswire/ — OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS) and other deadly cancers in kids and adults, today announced the appointment of Jutta Wanner, Ph.D., as its Chief Technology Officer. She is continuing to support the Next Generation Antibody Drug Conjugate (ADC) technology that she helped to develop at BlinkBio, which OS Therapies recently in-licensed.
At BlinkBio, Dr. Wanner was a member of the leadership team setting research strategy for chemistry and biology, developed business, and science focused company strategies. She developed the Medical and Computational Chemistry Group, represented Chemistry and Discovery in Board of Director, Scientific Advisory Board and Partnering/Collaboration meetings. Specifically, Dr. Wanner:
Established the Tunable Drug Conjugate (TDC) platform technology to deliver next generation Drug Conjugates
Developed the lead TDC program which targets Folate Receptor alpha (FRa) which
BEDFORD, Mass., Oct. 9, 2020 /PRNewswire/ — SpectraWAVE, Inc., a development-stage medical imaging company focused on improving coronary artery disease (CAD) outcomes with photonics, is pleased to announce that Eman Namati, Ph.D., has been appointed Chief Executive Officer. Dr. Namati brings more than a decade of experience leading the development and launch of highly technical medical imaging products.
Dr. Namati said, “The Board, founders, and team at SpectraWAVE have been an inspiring group to join. They are talented, experienced, and purpose-driven, which will be key as we move towards the launch of our new photonic imaging technology for coronary artery disease. Our flagship technology will define our clinical impact and growth, and we are working hard to bring that solution to the market to help as many patients as possible with coronary artery disease.”
“SpectraWAVE has the opportunity to help millions of patients worldwide,” according to Gregg Stone, MD,
Woebot Health announced today it has appointed Monique Levy to the newly-created position of Chief Commercial and Strategy Officer. Reporting to CEO Michael Evers, Levy is responsible for the growth and commercial success of the company’s proprietary therapeutic portfolio and measurement technologies that are designed to improve mental health. The appointment rounds out the company’s executive team, which also includes Founder and President Alison Darcy, Chief Clinical Officer Athena Robinson and Chief Technology Officer Casey Sackett.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005171/en/
Monique Levy, Chief Commercial and Strategy Officer, Woebot Health (Photo: Business Wire)
Evers, who joined Woebot Health in March, said Levy’s formidable experience building businesses and innovating care and health will be instrumental to the company’s next stage of development. “Monique’s training in clinical psychology and experience across some of the world’s most innovative data, digital health and therapeutics businesses bring incredible value